Literature DB >> 34926192

Anti-inflammatory and anti-apoptotic effects of N-acetylcysteine in diabetic rat corneal epithelium.

Sae-Byeok Hwang1,2, Jin Hyoung Park1,2,3, Ji-Yun Park4, Soon-Suk Kang2,5, Ho Seok Chung6, Hun Lee2,4, Jae Yong Kim2,4, Hungwon Tchah2,4.   

Abstract

AIM: To characterize the anti-inflammatory and anti-apoptotic effects of N-acetylcysteine (NAC) in streptozotocin (STZ)-induced diabetic rat corneal epithelium and human corneal epithelial cells (HCECs) exposed to a high-glucose environment.
METHODS: HCECs were incubated in 0, 5, 50 mmol/L glucose medium, or 50 mmol/L glucose medium with NAC for 24h. Diabetes was induced in rats by intraperitoneal injection of 65 mg/kg STZ and some of these rats were topically administered NAC to corneas with 3 mice per group. We characterized receptor for advanced glycation end-products (RAGE) expression using immunofluorescence, and interleukin (IL)-1β and cleaved caspase-3 (CCAP-3) expression using immunohistochemistry. Circulating tumor necrosis factor (TNF)-α concentration was measured by ELISA and cleaved poly-ADP ribose polymerase (PARP) concentration was quantified by Western blotting. Apoptotic cells were detected using TUNEL assay and annexin V and propidium iodide staining.
RESULTS: Diabetic rats had higher expression of RAGE (2.46±0.13 fold), IL-1β, and CCAP-3 in apoptotic cells of their corneas than control rats. The expression of RAGE (1.83±0.11 fold), IL-1β, and CCAP-3, and the number of apoptotic cells, were reduced by topical NAC treatment. HCECs incubated in 50 mmol/L glucose medium showed high concentrations of TNF-α (310±2.00 pg/mL) and cleaved PARP (7.43±0.56 fold), and more extensive apoptosis than cells in 50 mmol/L glucose medium. However, the addition of NAC reduced the concentrations of TNF-α (153.67±2.31 pg/mL) and cleaved PARP (5.55±0.31 fold) and the number of apoptotic cells.
CONCLUSION: NAC inhibits inflammation and apoptosis in the corneas of diabetic rats and HCECs maintained in a high-glucose environment. International Journal of Ophthalmology Press.

Entities:  

Keywords:  N-acetylcysteine; apoptosis; corneal epithelium; diabetes; inflammation; rat

Year:  2021        PMID: 34926192      PMCID: PMC8640769          DOI: 10.18240/ijo.2021.12.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  32 in total

Review 1.  AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

Authors:  A Bierhaus; M A Hofmann; R Ziegler; P P Nawroth
Journal:  Cardiovasc Res       Date:  1998-03       Impact factor: 10.787

2.  Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.

Authors:  Xiangzhe Li; Boram Kang; In Ho Woo; Youngsub Eom; Hyung Keun Lee; Hyo Myung Kim; Jong Suk Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

3.  Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy.

Authors:  Junghyun Kim; Chan-Sik Kim; Eunjin Sohn; Il-Ha Jeong; Hyojun Kim; Jin Sook Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-23       Impact factor: 3.117

4.  Diabetes inhibits corneal epithelial cell migration and tight junction formation in mice and human via increasing ROS and impairing Akt signaling.

Authors:  Qi-Wei Jiang; Denis Kaili; Jonaye Freeman; Chong-Yang Lei; Bing-Chuan Geng; Tao Tan; Jian-Feng He; Zhi Shi; Jian-Jie Ma; Yan-Hong Luo; Heather Chandler; Hua Zhu
Journal:  Acta Pharmacol Sin       Date:  2019-03-13       Impact factor: 6.150

Review 5.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

6.  N-acetylcysteine supplementation reduces oxidative stress for cytosine arabinoside in rat model.

Authors:  Yasemin Isik Balci; Semra Acer; Ramazan Yagci; Vural Kucukatay; Hakan Sarbay; Kerem Bozkurt; Aziz Polat
Journal:  Int Ophthalmol       Date:  2016-05-23       Impact factor: 2.031

7.  Cardioprotective potential of N-acetyl cysteine against hyperglycaemia-induced oxidative damage: a protocol for a systematic review.

Authors:  Phiwayinkosi V Dludla; Bongani B Nkambule; Stephanie C Dias; Rabia Johnson
Journal:  Syst Rev       Date:  2017-05-12

8.  High Concentration of Glucose Increases Reactive Oxygen Species Generation and Apoptosis Induced by Endoplasmic Reticulum Stress Pathway in Rabbit Corneal Epithelial Cells.

Authors:  Jiajun Lu; Minjie Sheng; Panpan Yao; Chaochao Ran; Hao Liu; Li Chen; Rui Liu; Bing Li
Journal:  J Ophthalmol       Date:  2018-07-08       Impact factor: 1.909

9.  Ameliorative Effects Of N-Acetylcysteine As Adjunct Therapy On Symptoms Of Painful Diabetic Neuropathy.

Authors:  Narges Heidari; Firozeh Sajedi; Younes Mohammadi; Mahtabalsadat Mirjalili; Maryam Mehrpooya
Journal:  J Pain Res       Date:  2019-11-19       Impact factor: 3.133

10.  N-Acetylcysteine causes analgesia in a mouse model of painful diabetic neuropathy.

Authors:  Serena Notartomaso; Pamela Scarselli; Giada Mascio; Francesca Liberatore; Emanuela Mazzon; Santa Mammana; Agnese Gugliandolo; Giorgio Cruccu; Valeria Bruno; Ferdinando Nicoletti; Giuseppe Battaglia
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.